D.C. Attorney General Brian L. Schwalb announced Friday that Indivior Inc., the maker of the opioid addiction treatment medication Suboxone, will pay the city about $2.3 million as part of a nationwide settlement resolving allegations the company planned an anticompetitive scheme to block generic competition for drug.
The post D.C. AG Announces $2.3M Settlement with Maker of Anti-Addiction Drug Suboxone appeared first on The Washington Informer.